Premium
S4‐04‐01: CSF amyloid lowering in human volunteers after 14 days’ oral administration of the novel BACE1 inhibitor E2609
Author(s) -
Albala Bruce,
Kaplow June M.,
Lai Robert,
Matijevic Mark,
Aluri Jagadeesh,
Satlin Andrew
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.08.023
Subject(s) - dosing , placebo , medicine , oral administration , clinical endpoint , pharmacology , pharmacokinetics , gastroenterology , randomized controlled trial , pathology , alternative medicine